This week’s plant medicine newsletter covers consumer trends in CBD use as a pharmaceutical substitute, the science of cannabinoids and alcohol, THC’s limitations as a driving impairment marker, and new research on cannabinoids in liver disease and breast cancer treatment.
Noteworthy Read
Many Consumers Report Substituting CBD for Traditional Medications (NORML)
A growing number of people are using CBD in place of conventional medications for conditions like anxiety, pain, sleep issues, and inflammation, according to a recent report. Survey findings suggest many consumers feel CBD offers relief with fewer side effects, reflecting a broader shift toward plant-based wellness tools alongside (or instead of) pharmaceutical treatments.
Read the articleView more in CBD
More Noteworthy Reading
THC Levels Are Unreliable Indicators of Driving Impairment (Leafie)
New research suggests that measuring THC in blood or saliva may not accurately reflect whether someone is actually impaired while driving. Because THC can linger in the body long after its psychoactive effects fade, the findings raise questions about current roadside testing approaches and highlight the complexity of cannabis and impairment.
Read moreView more in THC
Modulating the Endocannabinoid System in Alcohol Use Disorder (Molecular Psychiatry)
Scientists are exploring how the body’s endocannabinoid system may play a role in alcohol dependence and recovery. By influencing stress regulation, reward pathways, and emotional balance, cannabinoid signaling could become a target for future treatments aimed at reducing cravings and supporting long-term recovery.
Read moreView more in Endocannabinoid System
Research Round-Up
CBD and CBG May Help Reverse Fatty Liver Disease (ScienceDaily)
New research suggests that CBD and CBG may help reduce liver inflammation and fat buildup linked to metabolic disorders. Early findings indicate these cannabinoids could support healthier liver function by regulating inflammation and cellular stress responses.
Read moreView more in CBD
Cannabinoids in Combination With Conventional Breast Cancer Therapies (MDPI)
A scientific review explores how cannabinoids may complement standard breast cancer treatments by helping regulate inflammation, tumor growth signals, and treatment side effects. Researchers suggest cannabinoids could potentially enhance certain therapies while improving quality of life for patients.
Read moreView more in CBD
A heartfelt thank you to all of the CBD brands whose generous support powers Project CBD’s mission to bring you the latest in plant medicine research and journalism — we couldn’t do this work without you.
Be the first to comment